We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Stemline Therapeutics Inc | NASDAQ:STML | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.83 | 11.90 | 12.50 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-35619
Stemline Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
750 Lexington Avenue
Eleventh Floor
New York, NY 10022
(646) 502-2311
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | x | |||||
Rule 12g-4(a)(2) | o | |||||
Rule 12h-3(b)(1)(i) | x | |||||
Rule 12h-3(b)(1)(ii) | o | |||||
Rule 15d-6 | o | |||||
Rule 15d-22(b) | o |
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Stemline Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: | June 22, 2020 | By: | /s/ David G. Gionco | |||
Name: | David G. Gionco | |||||
Title: |
Senior Vice President of Finance and Chief Accounting Officer |
1 Year Stemline Therapeutics Chart |
1 Month Stemline Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions